LENSAR, Inc. (LNSR): Cash & Equivalents
$12.97M
As of 2025-12-31
$13.56M
As of 2026-06-30
-4.0%
3-year compound annual growth
-20.4%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.97M | -20.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $16.26M | -21.1% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $20.62M | +40.5% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $14.67M | -53.6% | 2024-03-04, Balance as of period end |
| 2021-12-31 | $31.64M | -22.1% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $40.60M | +779.7% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $4.62M | n/a | 2021-03-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $12.97M | -20.2% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $75.71M | -28.5% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $31.74M | 0.0% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $85.79M | +113.8% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $10.24M | -27.1% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $26.87M | +338.9% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $20.44M | +139.8% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $91.97M | -23.6% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $11.96M | +16.8% |
Compare LNSR, CVRX, APYX, CARL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗